House Panel Weighs Whether Low Generic Prices Spur Drug Shortages

Updated Story The House Energy & Commerce Committee is examining whether low generic drug prices are a key cause of U.S. drug shortages, hearing from a researcher Thursday (May 11) who found low generic drug prices affect the entire U.S. pharmaceutical supply chain by driving manufacturers to move their production elsewhere. The issue is a central part of an E&C oversight and investigations subcommittee hearing to ferret out the root causes of U.S. drug shortages, according to...